Daily FNArena News

Carsales posted a solid interim result and even more robust growth seems to be on the horizon

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Temple & Webster has suffered a weak start to the second half, but is it worth yesterday’s share price shellacking?

The superannuation disruptor segment has shrunk to half its peak size, with funds exiting the market in recent years having failed to resonate with the target audience

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

REA Group focuses on yield growth through price rises and deeper penetration, amid an uncertain listings environment

Michael Gable of Fairmont Equities suggests Whitehaven Coal may have seen a false break under the November low

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Tim Boreham reports Imagion’s CEO believes the oncology imaging innovator has achieved far more with its initial early-stage breast cancer study results than investors might appreciate.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments